Concepedia

Claudia P. Miller

CP

20

Publications

1.5K

Citations

17

H-Index

2004

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

United States Food and Drug Administration

Center for Drug Evaluation and Research

Claudia P. Miller is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and apoptosis.

Top concepts

Publications per year

2004–2025

20

Publications

20

Genome-Wide Analyses Identify Recurrent Amplifications of Receptor Tyrosine Kinases and Cell-Cycle Regulatory Genes in Diffuse Intrinsic Pontine Glioma

Barbara S. Paugh, Alberto Broniscer, Chunxu Qu et al. · Journal of Clinical Oncology · 2011 · 321 citations · Full text

NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells

Claudia P. Miller, Kechen Ban, Melanie Dujka et al. · Blood · 2007 · 203 citations · Full text

CXCL-12/Stromal Cell–Derived Factor-1α Transactivates HER2-neu in Breast Cancer Cells by a Novel Pathway Involving Src Kinase Activation

Neslihan Cabıoğlu, Justin M. Summy, Claudia P. Miller et al. · Cancer Research · 2005 · 157 citations · Full text

FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease–Associated Tumors

Jaleh Fallah, Michael H. Brave, Chana Weinstock et al. · Clinical Cancer Research · 2022 · 149 citations · Full text

, , +21

Exposure of Melanoma Cells to Dacarbazine Results in Enhanced Tumor Growth and Metastasis In Vivo

Dina Lev, Amir Onn, Vladislava O. Melinkova et al. · Journal of Clinical Oncology · 2004 · 129 citations

Rows per page

1–5 of 20